AIP
PAVM icon

Ameritas Investment Partners’s PAVmed PAVM Stock Holding History

Ameritas Investment Partners’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11
Closed -$7K – 3192
2022
Q1 		$7K Hold
11
– – ﹤0.01% 2895
2021
Q4 		$13K Hold
11
– – ﹤0.01% 2823
2021
Q3 		$44K Hold
11
– – ﹤0.01% 2244
2021
Q2 		$33K Hold
11
– – ﹤0.01% 2452
2021
Q1 		$23K Buy
11
+4
+57% +$6.01K ﹤0.01% 2510
2020
Q4 		$7K Hold
7
– – ﹤0.01% 2914
2020
Q3 		$6K Hold
7
– – ﹤0.01% 2928
2020
Q2 		$7K Buy
+7
New +$7K ﹤0.01% 2881

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's PAVM Position: Q2 2022 in Review

Ameritas Investment Partners sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 11 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in PAVM in Q2 2020 and held it in 8 quarters. The position peaked at $44K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • Ameritas Investment Partners reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 11 PAVmed shares in Q2 2022, an estimated $7K.
  • Ameritas Investment Partners first reported a position in PAVmed in Q2 2020 and held it in 8 quarters.
  • Ameritas Investment Partners's PAVmed position peaked at $44K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.